Haru Morita, President and CEO will speak at The 22nd DIA Japan Annual Meeting 2025

Haru Morita, President and CEO of our MODALIS, will speak at Session S21 on Monday, October 20, 2025, titled “Toward Tomorrow’s Norm: Patient-Driven Drug Development through Collaboration with Academia and Emerging Biopharma [Patient Engagement]” on Monday, October 20.

For details, please visit the conference website.
https://www.diajapan.org/meetings/25303/